Abstract:Background: Ischemic stroke (IS) is a leading cause of long-term disability and even mortality, threatening people's lives. Yinao Fujian (YNFJ) formula is a Traditional Chinese Medicine formula that has been widely used to treat patients with IS. However, the molecular mechanism of YNFJ for the treatment of IS is still elusive. Our study aimed to explore the potential protective effect and the underlying mechanisms of YNFJ on IS using a network pharmacology approach coupled with experimental validation. Materials and methods: Effective compounds of YNFJ were collected from BATMAN-TCM and TCMSP databases, while IS targets were obtained from GeneCards, OMIM, TTD and DrugBank databases. The protein-protein interaction (PPI) network was constructed to further screen the hub targets of YNFJ in IS treatment. GO and KEGG enrichment analyses were used to identify the critical biological processes and signaling pathways of YNFJ for IS. Moreover, Nissl staining, HE, TTC staining and Tunel staining were used in the MCAO model to prove the neuroprotective effect of YNFJ. Oxidative damage, inflammatory factor release and related pathways were tested in MCAO rat model and hypoxia-induced BV2 cell model, respectively. Results: We found that YNFJ treatment significantly alleviated MCAO-induced nerve damage and apoptosis. Then, network pharmacology screening combined with literature research revealed IL6, TNF, PTGS2, NFKBIA and NFE2L2 as the critical targets in a PPI network. Moreover, the top 20 signaling pathways and biological processes associated with the protective effects of YNFJ on IS were enriched through GO and KEGG analyses. Further analysis indicated that NF-κB and Nrf2/HO-1 signaling pathways might be highly involved in the protective effects of YNFJ on IS. Finally, in vitro and in vivo experiments confirmed that YNFJ inhibited the release of inflammatory factors (IL-6 and TNF-α) and MDA content, and increased the activity of SOD. In terms of the mechanism, YNFJ inhibited the release of inflammatory factors by suppressing the NF-κB pathway and decreased the expression of iNOS and COX-2 to protect microglia from inflammation damage. In addition, YNFJ initiated the dissociation of Keap-1 and Nrf2, and activated the downstream protein HO-1, NQO1, thus decreasing oxidative stress. Conclusion: Taken together, the findings in our research showed that the protective effects of YNFJ on IS were mainly achieved by regulating the NF-κB and Nrf2/HO-1 signaling pathways to inhibit oxidative stress damage and inflammatory damage of microglia.

The role of NPY signaling pathway in diagnosis, prognosis and treatment of stroke

[The Investigation of Syn and NPY Expression in Brain Tissues of Diabetic Model Rat Induced by Streptozotocin].

Plasma Neuropeptide Y and Cognitive Impairment after Acute Ischemic Stroke.

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Plasma Neuropeptide Y Levels and Adverse Clinical Outcomes after Acute Ischaemic Stroke.

Neuropeptide Y polymorphisms and ischemic stroke in Chinese population

Ligands of the Neuropeptide Y Y2 Receptors as a Potential Multitarget Therapeutic Approach for the Protection of the Neurovascular Unit Against Acute Ischemia/Reperfusion: View from the Perspective of the Laboratory Bench

Neuropeptide Y Expression in Mouse Hippocampus and Its Role in Neuronal Excitotoxicity

Impact of NBP on acute ischemic stroke: Tracking therapy effect on neuroinflammation

The Role of Neuropeptide Y in the Pathophysiology of Atherosclerotic Cardiovascular Disease

Serum Neuropeptide Y Level is Associated with Post-Ischemic Stroke Epilepsy.

A clinical study on levels of neuropeptide Y in plasma in patients with cerebrovascular disease

Promising Targets of Cell Death Signaling of NR2B Receptor Subunit in Stroke Pathogenesis

An update on the role of Hippo signaling pathway in ischemia-associated central nervous system diseases

Comprehensive Assessment of Ischemic Stroke in Nonhuman Primates: Neuroimaging, Behavioral, and Serum Proteomic Analysis

Diverse Functions and Mechanisms of Pericytes in Ischemic Stroke

Neurogranin: A Potential Biomarker of Neurological and Mental Diseases

Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives

A promising frontier: targeting NETs for stroke treatment breakthroughs

Neuro- and vasoprotective potential of neuropeptide Y2 receptor agonist, NPY13-36, against transient focal cerebral ischemia in spontaneously hypertensive rats

Exploring the Molecular Mechanism of Yinao Fujian Formula on Ischemic Stroke Based on Network Pharmacology and Experimental Verification